Drug Candidate
PMI04
Summary
Potential first-in-class imaging agent for
neuroinflammation/neurodegenerative diseases
Mechanism of Action
PET/SPECT ligand targeting CSF1R
Indication
PD, AD, ALS and Depression
Development Stage
Phase I
PMI04
PMI04
Potential first-in-class imaging agent for
neuroinflammation/neurodegenerative diseases
PET/SPECT ligand targeting CSF1R
PD, AD, ALS and Depression
Phase I